Investor Ideas ‘Potcast’; #Cannabis News
and Stocks on the Move; (CSE: $BE.C), (TSXV:
$SCYB.V), (OTCQX: $GRWG), (TSXV: $GENE.V), (OTC: $IVITF)
Pt. Roberts, WA; Delta, BC – May 16, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of
its new series, Investorideas.com potcasts - cannabis news and stocks to watch plus
insight from thought leaders and experts.
Read this news in full at http://www.investorideas.com/news/2018/cannabis/05162Potcast-StocksToWatch.asp
Listen to the podcast:
Today’s podcast overview/transcript:
Good afternoon and welcome to
Investorideas.com potcasts following cannabis news, stocks to watch as
well as insight from thought leaders and experts. Today we are going over some
of the day’s cannabis highlights focusing on Beleave Inc.( CSE: BE and OTCQX
as BLEVF) Scythian Biosciences Corp
(TSX
V: SCYB) GrowGeneration Corp ( OTCQX:GRWG )
and INVICTUS MD STRATEGIES CORP (TSXV:GENE and OTC : IVITF).
Starting with a look at Beleave Inc. who announced earlier today that
its wholly owned subsidiary Beleave Kannabis Corp. has received its approval
and provider number to service those who have qualified for cannabis coverage
through Medavie Blue Cross including the Canadian veteran community. With
over 1,000,000 card holders Medavie Blue Cross is one of Canada's leading Blue
Cross plans and although each card holder's benefits may differ, cannabis
coverage is available to patients approved by Blue Cross
Beleave CEO Andrew Wnek
was quoted saying "We aim to help provide ease of access to those with
Blue Cross coverage allowing patients to cut a multitude of steps typically
needed to make a claim, Our team is ready to accept new patients and are
confident in our ability to provide the highest quality service to all patients
including our country's respected servicemen and women."
Next looking at Scythian Biosciences Corp. who announced that
Colombian-based ColCanna SAS, a company that Scythian is in the process of
acquiring, has received a licence for the cultivation and importation of
non-psychoactive cannabis (“CBD”) by the Ministry of Justice
and Law of Colombia. Additionally, ColCanna has entered into an exclusive
international supply agreement for Colombia
with Aphria Inc., trading on the TSX as APH.TO which is one of the larger Canadian low-cost
producer of medical cannabis.
“Through the expansion of our partnership with Aphria, it is with great
pleasure that I announce our entry into the Colombia market as the first
supplier of Aphria’s pharma grade medicinal CBD oil in the country,” said CEO
Rob Reid. “As we work to finalize the acquisition of ColCanna, we are eager to
work hand and hand with Aphria to establish ColCanna as an international
supplier of research-backed cannabis products.”
ColCanna is the first
cultivator to receive a licence to grow CBD in the Colombian coffee zone.
ColCanna has additional pending licences to cultivate THC and for the
extraction and exportation of CBD and THC extracts.
Located in a temperate
climate that supports four harvests a year, the first of which is expected in
late 2018, this area is ideal for year-round cultivation without the need for
artificial climate control. Currently, ColCanna is constructing over 500,000 square
feet of total greenhouse production space and is planning to build its
laboratory for the fabrication of cannabis extracts in a warehouse in Pereira.
Following construction, ColCanna anticipates these facilities will be capable
of producing over 2,600,000 ml of medicinal oil per year.
“We look forward to
bringing the first cannabis grown in the hallowed soil of the coffee zone to
hospitals, doctors and researchers across Colombia and eventually the
international market” said CEO Rob Reid. “The pure, high grade, medicinal
CBD will offer those in need the highest calibre medical treatment, and
advances Scythian’s mission to remain on the vanguard of medical research.”
GrowGeneration
Corp. released their 1st
quarter financial reports earlier today. GrowGeneration is one of the largest
specialty retail hydroponic and organic gardening stores, selling to both the
commercial and home cannabis markets.
Some
of the 1st quarter highlights included Revenue of
$4.4 million, up 70% compared to revenue of $2.6 million for the 1st quarter of
2017.
Darren Lampert, Co-Founder and CEO,
said, "This was another great quarter of sales for GrowGeneration, clearly
demonstrating the demand for our products and the scalability of our business
as we continue our expansion plans." Further, Lampert stated, "our
company continues to attract capital, raising $10.2 million in debt and equity
financing for the quarter, strengthening our balance sheet to $8.8 million in cash
and $14.3 million in working capital. Today, we have a strong balance sheet of
almost $18 million in cash and strong strategic partners in Gotham Green
Partners, Merida Capital Partners and Navy Capital. Our acquisition pipeline is
robust, totaling over $25 million. For 2018, the company has set revenue
guidance at $37 million."
And finally
looking at INVICTUS MD STRATEGIES CORP. who also made announcements today that
it has entered into a binding letter of intent for an option to acquire 100% of
the outstanding shares of OptionCo
OptionCo has two properties. One is
located in Delta, British Columbia ("Delta Facility") and is a state
of the art, pharmaceutical grade, cannabis production and research facility,
which has been submitted to Health Canada for final review and approval under
the ACMPR. The Company expects to receive its cultivation license for the Delta
Facility in second quarter of 2018. The other property is located in Mission, British Columbia ("Mission Location"). The Mission
Location application under the ACMPR has been submitted and is awaiting
construction of its first 50,000 square foot state of the art, pharmaceutical
grade purposed built indoor facility
Subject
to completion of satisfactory due diligence, Invictus intends to enter into a
definitive option agreement for the purchase of the OptionCo on or before June 30, 2018.Dan Kriznic, CEO and Chairman commented "This is a significant milestone for Invictus as we round out our ACMPR licenses through out the country. OptionCo will give us a significant footprint in British Columbia already adding to our large footprint in Alberta and Ontario. As we continue to build out our retail and distribution strategy, we need to have additional capacity and plan to aggressively build out the expansion in the short term as we gear up for the legalization of recreational cannabis."
Invictus owns and operates cannabis
companies in Canada with the vision of producing
a variety of high quality and low cost cannabis products and strains to the global
market place and the companies Chief Evangelist Officer is none other then
music legend Gene Simmons
That’s our cannabis stock news for today. Lots of acquisitions in the
works which will be good to keep an eye on moving towards this Friday when the
ACMPR licenses are typically issued.
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
To sponsor this podcast or be a guest
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment